StratGraph
Companies / Materials
DOW

Dow Inc.

Commodity Chemicals

Commodity ChemicalsAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health23
Growth5
Profitability0
Cash generation5
Balance sheet33
Dilution control71
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)13.0%Revenue growth (FY)-7.0%Revenue CAGR (3y)-11.1%Gross margin6.3%Operating margin—Net margin-6.1%Free cash flow margin-3.6%R&D / revenue1.9%Stock comp / revenue0.4%Net debt / operating cash flow13.60xCurrent ratio1.97Diluted share count change0.9%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$55.0B$56.9B$44.6B$43.0B$40.0B
Gross profit$10.8B$8.6B$4.9B$4.6B$2.5B
Net income$6.4B$4.6B$660M$1.2B-$2.4B
Operating cash flow$7.0B$7.5B$5.2B$2.9B$1.0B
Capital expenditure$1.5B$1.8B$2.4B$2.9B$2.5B
Free cash flow$5.5B$5.7B$2.8B-$26M-$1.4B
R&D$857M$851M$829M$810M$752M
Stock-based comp$276M$211M$212M$159M$154M
Buybacks$1.0B$2.3B$625M$494M$0
Dividends$2.1B$2.0B$2.0B$2.0B$1.5B
Cash$3.0B$3.9B$3.0B$2.2B$3.8B
Total debt$14.7B$15.4B$15.0B$15.7B$17.8B
Equity$18.2B$20.7B$18.6B$17.4B$16.0B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.